Biolargo Inc (BLGO) financial statements (2022 and earlier)

Company profile

Business Address 14921 CHESTNUT ST.
WESTMINSTER, CA 92683
State of Incorp. DE
Fiscal Year End December 31
SIC 28 - Chemicals And Allied Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9627166556559901,9101,763
Cash and cash equivalents9627166556559901,9101,763
Receivables513484355257946841
Inventory, net of allowances, customer advances and progress billings2412771626543437
Inventory2412771626543437
Prepaid expense      49
Other undisclosed current assets85283917204 
Total current assets:1,8011,5051,0659551,1592,0171,891
Noncurrent Assets
Operating lease, right-of-use asset453341411
Property, plant and equipment61609512610959 
Long-term investments and receivables4863     
Long-term investments4863     
Intangible assets, net (including goodwill) 2,1501,8931,893   
Intangible assets, net (excluding goodwill) 2,1501,8931,893   
Prepaid expense591788     
Other noncurrent assets69353535333719
Other undisclosed noncurrent assets  122176195  
Total noncurrent assets:1,2223,4372,5562,2303379619
TOTAL ASSETS:3,0234,9423,6213,1851,4952,1131,910
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:559513602501224200325
Accounts payable35031546530217222 
Employee-related liabilities1841561277 218 
Interest and dividends payable2542125122514013
Other undisclosed accounts payable and accrued liabilities    1(80)312
Deferred revenue894835
Debt3141,2065,064  610 
Derivative instruments and hedges, liabilities     664 
Customer advances and deposits  135
Other undisclosed current liabilities4121,777(1,347)1,9903,992(319) 
Total current liabilities:1,3743,5444,3542,4914,2161,155460
Noncurrent Liabilities
Long-term debt and lease obligation5297339861,292 5,2513,246
Long-term debt, excluding current maturities1805077001,292 5,2513,246
Operating lease, liability349226286
Liabilities, other than long-term debt 900     
Financial instruments subject to mandatory redemption, settlement terms, share value, amount 900     
Other undisclosed noncurrent liabilities(162) 461525689(3,522)(2,937)
Total noncurrent liabilities:7161,6331,4471,8176891,728309
Total liabilities:2,0905,1775,8014,3084,9052,883769
Stockholders' equity
Stockholders' equity attributable to parent, including:4,6533,858(2,153)(1,496)(4,104)(1,325)1,141
Common stock17115111195706257
Additional paid in capital143,718135,849121,327110,22297,09390,61084,411
Accumulated other comprehensive loss(115)(101)(99)(90)(62)(82)(41)
Accumulated deficit(139,121)(132,041)(123,492)(111,723)(101,205)(91,915)(84,076)
Other undisclosed stockholders' equity attributable to parent      790
Stockholders' equity attributable to noncontrolling interest(3,720)(4,093)(27)373695555 
Total stockholders' equity:933(235)(2,180)(1,123)(3,410)(770)1,141
TOTAL LIABILITIES AND EQUITY:3,0234,9423,6213,1851,4952,1131,910

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2,5312,4321,8611,364516281128
Revenue, net516281227
Cost of revenue(1,428)(1,204)(945)(743)(323)(106)(62)
Cost of goods and services sold(1,428)(1,204)(945)(743)  (62)
Gross profit:1,1031,22891662119317566
Operating expenses(7,539)(8,811)(7,612)(7,033)(6,059)(5,096)(4,247)
Other undisclosed operating loss    (30)(14) 
Operating loss:(6,436)(7,583)(6,696)(6,412)(5,895)(4,935)(4,181)
Nonoperating expense
(Other Nonoperating expense)
(458)(2,117)(4,744)(4,284)(3,651)  
Interest and debt expense(234)(2,365)(1,029)(276)(3,862)(3,129)(995)
Loss from continuing operations before equity method investments, income taxes:(7,128)(12,065)(12,469)(10,972)(13,409)(8,064)(5,176)
Loss from equity method investments(15)(37)     
Loss before gain (loss) on sale of properties:(7,143)(12,102)(12,469)(10,972)(13,409)(8,064)(5,176)
Other undisclosed net income (loss)2492,4021,0292763,862(10)99
Net loss:(6,894)(9,700)(11,440)(10,696)(9,547)(8,074)(5,077)
Net income attributable to noncontrolling interest     23521
Net loss attributable to parent:(6,894)(9,700)(11,440)(10,696)(9,547)(7,840)(5,056)
Other undisclosed net income (loss) available to common stockholders, basic(186)1,268750475429  
Net loss available to common stockholders, diluted:(7,080)(8,432)(10,690)(10,221)(9,117)(7,840)(5,056)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(6,894)(9,700)(11,440)(10,696)(9,547)(8,074)(5,077)
Other comprehensive loss      (5,118)
Other undisclosed comprehensive income (loss)(14)(2)(9)(28)19(41) 
Comprehensive loss:(6,908)(9,702)(11,449)(10,724)(9,527)(8,115)(10,195)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(186)1,26875047542923521
Comprehensive loss, net of tax, attributable to parent:(7,094)(8,434)(10,699)(10,249)(9,098)(7,881)(10,174)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: